A Randomised, Placebo-controlled Trial of Erythropoietin in ICU Patients With Traumatic Brain Injury.
Phase of Trial: Phase III
Latest Information Update: 30 Sep 2017
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Traumatic-brain-injuries
- Focus Biomarker; Therapeutic Use
- Acronyms EPO-TBI
- 07 Oct 2015 Results published online in the Lancet.
- 07 Oct 2015 Primary endpoint has not been met. (Improvement in neurological status)
- 29 Mar 2012 Additional locations added as reported by European Clinical Trials Database record.